A critical review

Epidemiology

Volumn 25, Issue 1, 2014, Pages 114-121

  Kerr, Kathleen F ^a   Wang, Zheyu ^a   Janes, Holly ^a   McClelland, Robyn L ^a   Psaty, Bruce M ^b   Pepe, Margaret S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; DATA ANALYSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NET RECLASSIFICATION INDEX; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; CONFIDENCE INTERVAL; HUMAN; REGRESSION ANALYSIS; STATISTICS;

CONFIDENCE INTERVALS; HUMANS; REGRESSION ANALYSIS; RISK ASSESSMENT; STATISTICS AS TOPIC;

EID: 84890117399     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0000000000000018     Document Type: Review

References (21)

1. W ilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847
2. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879-1886
3. 27th Bethesda Conference. Matching the intensity of risk factor management with the hazard for coronary disease events. J Am Coll Cardiol. 1996;27:957-1047
4. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157-172; discussion 207
5. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11-21
6. Greenland P, O'Malley PG. When is a new prediction marker useful? A consideration of lipoprotein-Associated phospholipase A2 and C-reactive protein for stroke risk. Arch Intern Med. 2005;165:2454-2456
7. Peirce CS. The numerical measure of the success of predictions. Science. 1884;4:453-454
8. Polonsky TS, McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303:1610-1616
9. L eening MJ, Steyerberg EW. Fibrosis and mortality in patients with dilated cardiomyopathy. JAMA. 2013;309:2547-2548
10. Pickering JW, Endre ZH. New metrics for assessing diagnostic potential of candidate biomarkers. Clin J Am Soc Nephrol. 2012;7:1355-1364
11. Pepe MS. Problems with risk reclassification methods for evaluating prediction models. Am J Epidemiol. 2011;173:1327-1335
12. Pencina MJ, D'Agostino RB, Pencina KM, Janssens AC, Greenland P. Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol. 2012;176:473-481
13. Kerr KF, Bansal A, Pepe MS. Further insight into the incremental value of new markers: The interpretation of performance measures and the importance of clinical context. Am J Epidemiol. 2012;176:482-487
14. Greenland S. The need for reorientation toward cost-effective prediction: Comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929). Stat Med. 2008;27:199-206
15. Hilden J, Gerds TA. A note on the evaluation of novel biomarkers: Do not rely on integrated discrimination improvement and net reclassification index [published online ahead of print 2 April 2013]. Stat Med. doi: 10.1002/sim.5804
16. Pepe M, Fang J, Feng Z, Gerds T, Hilden J. The Net Reclassification Index (NRI): A Misleading Measure of Prediction Improvement with Miscalibrated or Overfit Models. UW Department of Biostatistics Working Paper Series. 2013; Paper 392
17. V an Calster B, Vickers AJ, Pencina MJ, Baker SG, Timmerman D, Steyerberg EW. Evaluation of markers and risk prediction models: Overview of relationships between NRI and decision-Analytic measures. Med Decis Making. 2013;33:490-501
18. Pepe MS, Feng Z, Gu JW. Comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929). Stat Med. 2008;27:173-181
19. Pepe MS, Kerr KF, Longton G, Wang Z. Testing for improvement in prediction model performance. Stat Med. 2013;32:1467-1482
20. C ook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928-935
21. Uno H, Tian L, Cai T, Kohane IS, Wei LJ. A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data. Stat Med. 2013;32:2430-2442